Hot Features
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antivi... Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 2927 | 2.738E-5 | CS |
| 52 | -0.0002 | -66.6666666667 | 0.0003 | 0.0004 | 1.0E-6 | 2005 | 8.096E-5 | CS |
| 156 | -0.120915 | -99.9173656158 | 0.121015 | 0.1448 | 1.0E-6 | 23195 | 0.06382759 | CS |
| 260 | -2.0899 | -99.995215311 | 2.09 | 2.88 | 1.0E-6 | 27992 | 0.52842659 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.